ZTS
29
2
VTR
55
-2
ABT
63
-2
COST
48
3
LH
42
2
CMS
53
-4
ACN
33
4
GILD
65
-3
NOC
45
4
XEL
58
-7
WDC
41
3
CVS
45
-2
MS
69
3
MAR
54
12
ALLE
71
-2
ALL
64
-2
MRK
41
6
PHM
48
-4
MUR
31
2
AVY
47
-4
ZTS
29
2
VTR
55
-2
ABT
63
-2
COST
48
3
LH
42
2
CMS
53
-4
ACN
33
4
GILD
65
-3
NOC
45
4
XEL
58
-7
WDC
41
3
CVS
45
-2
MS
69
3
MAR
54
12
ALLE
71
-2
ALL
64
-2
MRK
41
6
PHM
48
-4
MUR
31
2
AVY
47
-4
Financhill
Back

United-Guardian 10K Form

Buy
52

UG
United-Guardian

Last Price:
$7.90
Seasonality Move:
5.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UG News And Ratings

See the #1 stock for the next 7 days that we like better than UG

UG Financial Statistics

Sales & Book Value

Annual Sales: $12.2M
Cash Flow: $-45.9K
Price / Cash Flow: 12.63
Annual Sales: $2.59
Price / Book: 3.22

Profitability

EPS (TTM): 0.71000
Net Income (TTM): $3.3M
Gross Margin: $6.5M
Return on Equity: 28.06%
Return on Assets: 24.31%

United-Guardian Earnings Forecast

Key United-Guardian Financial Ratios

  • The Gross Profit Margin over the past 41 years for UG is 53.03%.
  • The Selling, General & Administrative Expenses for UG have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 3.75% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of UG is 26.69% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 26 years.

United-Guardian Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Personal Care Products
Sector: Consumer Staples
Current Symbol: UG
CUSIP: 910571
Website: u-g.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.62
Quick Ratio: 5.66

Price-to-Earnings

Trailing P/E Ratio: 11.75
Forward P/E Ratio: 0

UG Technical Analysis vs Fundamental Analysis

Buy
52
United-Guardian (UG) is a Buy

Is United-Guardian a Buy or a Sell?

  • United-Guardian stock is rated a Buy
    The current United-Guardian [UG] share price is $8.34. The Score for UG is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.